In silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy – SILICOFCM.
6 October 2019 (09:30 - 09:38)
Organised by:
Slides
About the speaker
Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia)
4 More presentations in this session
Miss K. Groenhof (Utrecht, NL)
Mrs K. Proniewska (Krakow, PL)
Professor A. Leber (Munich, DE)
Access the full session
The Event
Digital Health 2019
6 October 2019
09:30 CET
